![January/February 2023: A 24-week, All-Oral Regimen for Rifampin-Resistant Tuberculosis](https://icap.columbia.edu/wp-content/uploads/resource-image-fix.jpg)
Tuberculosis
![January/February 2023: A 24-week, All-Oral Regimen for Rifampin-Resistant Tuberculosis](https://icap.columbia.edu/wp-content/uploads/resource-image-fix.jpg)
Reasons for poor uptake of TB preventive therapy in South Africa
Authors: D P Baloyi, M G Anthony, K A Meyerson, S Mazibuko, D Wademan, L Viljoen, H Myburgh, K du Preez, M Osman, Y Hirsch-Moverman, S Charalambous, H Hausler, A C Hesseling, G Hoddinott Abstract: Background: South Africa has one the highest TB and HIV burdens...Effectiveness of a Community-based Intervention to Prevent Childhood TB in Lesotho
Abstract: BACKGROUND: Child contact management (CCM) is a recognized strategy to prevent TB; however, implementation is suboptimal. PREVENT was a cluster-randomized trial that evaluated the effectiveness and acceptability of a community-based intervention (CBI) to...![March 2022: Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children](https://icap.columbia.edu/wp-content/uploads/2018/05/Tuberculosis-e1648651451684-1080x675.jpg)
March 2022: Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children
Article and Study Summary: Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children Published in: New England Journal of Medicine 2022;386(10):911-922. https://www.nejm.org/doi/full/10.1056/NEJMoa2104535 Authors: Turkova A, Wills GH, Wobudeya E, et...![January 2022: Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis](https://icap.columbia.edu/wp-content/uploads/Untitled-design-3-1-1080x675.png)